Results 131 to 140 of about 13,685 (176)

A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis. [PDF]

J Infect Dis
Cho H, Paun A, Seo Y, Lee SH, Traver M, Zhao M, Skinner J, Tan J, Sacks DL, Crompton PD.   +9 more
europepmc   +1 more source

Modulation of fibroblast behavior by Leishmania: a pathway to understanding disease progression in cutaneous leishmaniasis. [PDF]

BMC Microbiol
de Queiroz Filho TN, Costa BF, Rodrigues APD.   +2 more
europepmc   +1 more source

Impact of 2D versus 3D fibroblast models on <i>Leishmania</i> species invasion <i>in vitro</i>: Rab5 dynamics and actin activity in initial infection. [PDF]

Front Cell Infect Microbiol
Santa Brígida RTS, Carneiro ALDC, Franco FTC, Costa BF, Rodrigues APD.   +4 more
europepmc   +1 more source

Topical microemulsion with phenolic compounds from Libidibia ferrea (Fabaceae): An alternative treatment for cutaneous leishmaniasis. [PDF]

Eur J Microbiol Immunol (Bp)
Jensen BB, Cardoso Rodrigues Dos Santos KS, Comandolli-Wyrepkowski CD, Araujo da Silva FM, Coutinho de Souza C, da Paz Lima M, Marques Barcellos JF, Pereira de Souza T, Araújo Rolim FN, Pinheiro FG, Ramos Franco AM.   +10 more
europepmc   +1 more source

[Nipple involvement in diffuse cutaneous leishmaniasis (DCL) produced by Leishmania (L) amazonensis].

Revista da Sociedade Brasileira de Medicina Tropical, 1995
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In vitro efficacy of isoflavonoids and terpenes against Leishmania (Leishmania) infantum and L. amazonensis

Experimental Parasitology, 2022
The main form of control of leishmaniasis is the treatment, however various side effects and poor efficacy are associated with presently available drugs. The investigation of bioactive natural products for new antileishmanial drugs is a valid approach.
Iasmin Aparecida Cunha, Araújo, Renata Cristina, De Paula, Ceres Luciana, Alves, Karen Ferraz, Faria, Marco Miguel de, Oliveira, Gabriela Gonçalves Mendes, Takarada, Eliane Maritns Ferreira Abdias, Dias, Alaíde Braga de, Oliveira, Sydnei Magno da, Silva   +8 more
openaire   +2 more sources

Assessing the effects of Leishmania (Leishmania) infantum and L. (L.) amazonensis infections in macrophages using a quantitative proteome approach

Experimental Parasitology, 2022
Leishmania (Leishmania) infantum is the causative agent of visceral leishmaniasis, while L. (L.) amazonensis is associated with localized cutaneous and diffuse leishmaniasis, which can affect different organ tissues leading to visceral manifestations in some hosts.
Ivana H.R. Oliveira, Frank Kjeldsen, Marcella N. Melo-Braga, Thiago Verano-Braga, Hélida M. de Andrade   +4 more
openaire   +3 more sources

Attempt to differentiate Leishmania (Leishmania) amazonensis, L. (L.) chagasi, Leishmania (Viannia) braziliensis and L. (V.) guyanensis using the SSR-PCR technique

Parasitology Research, 2001
The ability to differentiate reference strains of Leishmania (Leishmania) amazonensis, L. (L.) chagasi, Leishmania (Viannia) braziliensis and L. (V.) guyanensis was evaluated using the simple sequence repeat polymerase chain reaction (SSR-PCR) technique.
A C, Volpini, V M, de Azeredo Passos, A J, Romanha   +2 more
openaire   +2 more sources

PCR-RFLP to identify Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis causing American cutaneous leishmaniasis

Acta Tropica, 2004
A PCR-RFLP based method was developed to diagnose and identify the Leishmania species causing American cutaneous leishmaniasis (ACL) in a panel of clinical samples obtained from an endemic region of Brazil. The comparison of the results obtained by PCR-RFLP and PCR-hybridization in the identification of Leishmania (Viannia) braziliensis and L ...
Angela C, Volpini, Valéria M A, Passos, Guilherme Correa, Oliveira, Alvaro J, Romanha   +3 more
openaire   +2 more sources